Invention Grant
- Patent Title: Anti CD37 antibodies
-
Application No.: US14693047Application Date: 2015-04-22
-
Publication No.: US09932399B2Publication Date: 2018-04-03
- Inventor: Karl-Heinz Heider , Eric Borges , Elinborg Ostermann
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Edouard G. Lebel; David J. Kershner; Gabriel J. McCool
- Priority: EP07114128 20070809
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A01K67/027 ; A61K39/395 ; A61K45/06 ; C07K16/30 ; A61K39/00
Abstract:
Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B cell malignancies and autoimmune and inflammatory diseases that involve B cells in their pathology.
Public/Granted literature
- US20160137729A1 ANTI CD37 ANTIBODIES Public/Granted day:2016-05-19
Information query
